Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass

British Journal of Anaesthesia

Volumn 90, Issue 2, 2003, Pages 122-126

  Yoshitani, K ^a   Kawaguchi, M ^a   Takahashi, M ^a   Kitaguchi, K ^a   Furuya, H ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anaesthetics i.v., propofol; Monitoring, electroencephalography; Surgery, cardiovascular

Indexed keywords

FENTANYL; PROPOFOL;

ADULT; AGED; AORTA CLAMPING; ARTICLE; AWARENESS; BODY TEMPERATURE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISPOSITION; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INFORMED CONSENT; INTRAOPERATIVE PERIOD; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL;

EID: 0037311785     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg010     Document Type: Article

References (17)

1. Holley FO, Pongains KV, Stanski DR, et al. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharmacokinet 1982; 7: 234-51
2. Andersson LG, Bratteby LE, Ekroth R, et al. Renal function during cardiopulmonary bypass: influence of pump flow and systemic blood pressure. Eur J Cardiothorac Surg 1994; 8: 597-602
3. Hampton WW, Townsend MC, Schirmer WJ, et al. Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 1989; 124: 458-9
4. Hynynen M, Hammaren E, Rosenberg PH. Propofol sequestration within the extracorporeal circuit. Can J Anaesth 1994; 41: 583-8
5. Hammaren E, Yli-Hankala A, Rosenberg PH, et al. Cardiopulmonary bypasss-induced changes in plasma concentrations of propofol and auditory evoked potentials. Br J Anaesth 1996; 77: 360-4
6. Dawson PJ, Bjorksten AR, Blake DW, et al. The effect of cardiopulmonary bypass on total and unbound plasma concentrations of propofol and midazolam. J Cardiovasc Anaesth 1997; 11: 556-61
7. Schmidlin D, Hager P, Schmid ER. Monitoring level of sedation with bispectral EEG analysis: comparison between hypothermic and normothermic cardiopulmonary bypass. Br J Anaesth 2001; 86: 769-76
8. Shafer SL. Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth 1993; 5 (Suppl 1): 14S-21S
9. Marsh B, White M, Kenny GNC. Pharmacokeinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41-8
10. Coetzee JF, Glen JB, Wium CA, et al. Pharmacokinetic model selection for target controlled infusions of propofol-assessment of three parameter sets. Anesthesiology 1995; 82: 1328-45
11. Rampil IJ. A primer for EEG signal processing in anesthesia. Anesthesiology 1998; 89: 980-1002
12. Russell GN, Wright EL, Fox MA, et al. Propofol-fentanyl anaesthesia for coronary artery surgery and cardiopulmonary bypass. Anaesthesia 1989; 44: 205-8
13. McMurray TJ, Collier PS, Carson IW, Lyons SM, Elliott P. Propofol sedation after open heart surgery: a clinical and pharmacokinetic study. Anaesthesia 1990; 45: 322-6
14. Doyle PW, Matta BF. Burst suppression or isoelectric encephalogram for cerebral protection: evidence from metabolic suppression studies. Br J Anaesth 1999; 83: 580-4
15. VanHemelrijck J, Tempelhoff R, White PF, et al. EEG-assisted titration of propofol infusion during neuroanesthesia: Effect of nitrous oxide. J Neurosurg Anesth 1992; 4: 11-20
16. Kumar K, Crankshaw DP, Morgan DJ, et al. The effect of cardiopulmonary bypass on plasma protein bindings of alfentanil. Eur J Clin Pharmacol 1988; 35: 47-52
17. Hirschi M, Meistelman C, Longrois D. Effects of normothermic cardiopulmonary bypass on bispectral index. Eur J Anaesthesiol 2000; 17: 499-505